Kestra Medical director granted 7,217 RSUs

KMTS director Elizabeth Kwo received a 7,217-unit restricted stock award that vests in 2027, increasing her reported direct holdings to 18,126 common shares.

Rhea-AI Filing Summary

KESTRA MEDICAL TECHNOLOGIES, LTD. (symbol: KMTS) is the issuer of record for a Form 4 filing submitted to the SEC. Kwo Elizabeth reported acquisition or exercise transactions in this Form 4 filing.

KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) reported that director Elizabeth Kwo received a grant of 7,217 restricted stock units, each representing one common share. After this award, she has 18,126 common shares reported as directly held. The restricted stock units vest on September 9, 2027, subject to her continued service through that date. No Rule 10b5-1 trading plan is reported for this transaction.

Insider Trade Summary

Grant/Award: 7,217 shares

Grant/Award 1 txn

Insider Kwo Elizabeth

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares F1	7,217	--	--

Holdings After Transaction: Common Shares — 18,126 shares (Direct)

Footnotes (1)

1. F1. The reported securities represent restricted stock units which each entitle the reporting person to receive one common share of the Issuer. The restricted stock units will vest on September 9, 2027, subject to the reporting person's continued service through such date.

Key Figures

Restricted stock units granted: 7,217 units Shares held after transaction: 18,126 common shares RSU vesting date: September 9, 2027

3 metrics

Restricted stock units granted 7,217 units Equity award reported for September 9, 2026

Shares held after transaction 18,126 common shares Director’s direct holdings following the grant

RSU vesting date September 9, 2027 Restricted stock units vest subject to continued service through this date

Key Terms

restricted stock units, reporting person, Grant, award, or other acquisition

3 terms

restricted stock units financial

"The reported securities represent restricted stock units which each entitle"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

reporting person regulatory

"subject to the reporting person's continued service through such date"

Grant, award, or other acquisition regulatory

"transaction code description is Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did KMTS disclose for director Elizabeth Kwo?

KMTS disclosed that director Elizabeth Kwo received a grant of 7,217 restricted stock units on September 9, 2026, as an acquisition of common-share-linked equity compensation, bringing her reported direct holdings to 18,126 common shares after the award.

How many KMTS shares does Elizabeth Kwo hold after this Form 4 transaction?

After the reported transaction, Elizabeth Kwo is shown as directly holding 18,126 common shares of KMTS. This total reflects the impact of the 7,217 restricted stock units granted in this filing.

What type of KMTS security was granted to Elizabeth Kwo in this filing?

The filing states that the reported securities are restricted stock units, with each unit entitling the reporting person to receive one common share of KMTS, subject to vesting conditions.

When do the restricted stock units granted to the KMTS director vest?

The restricted stock units granted to the director are scheduled to vest on September 9, 2027, provided the reporting person continues in service with the company through that date.

Was the KMTS insider transaction made under a Rule 10b5-1 trading plan?

No. The Form 4 indicates that the Rule 10b5-1 checkbox is not marked affirmatively, so no Rule 10b5-1 trading plan is reported in connection with this equity grant.

Is the KMTS Form 4 transaction a market purchase or sale?

The transaction is reported with a code for grant, award, or other acquisition of securities, not as a market purchase or sale. It reflects an equity compensation award of restricted stock units to the director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 08:32 PM Accepted by SEC EDGAR 09/10/2026 - 08:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kwo Elizabeth

(Last) (First) (Middle)

C/O KESTRA MEDICAL TECHNOLOGIES, LTD.

3933 LAKE WASHINGTON BLVD NE, SUITE 200

(Street)

KIRKLAND WASHINGTON 98033

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KESTRA MEDICAL TECHNOLOGIES, LTD. [ KMTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	09/09/2026		A		7,217(1)	A	(1)	18,126	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported securities represent restricted stock units which each entitle the reporting person to receive one common share of the Issuer. The restricted stock units will vest on September 9, 2027, subject to the reporting person's continued service through such date.

	/s/ Traci S. Umberger as attorney-in-fact for Elizabeth Kwo	09/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)